Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Neural Technology Research Centers Launched

Research centers for accelerating new technologies that tackle nervous system disorders are opening at two universities in the U.S., with industry partners. . . . → Read More: Neural Technology Research Centers Launched

FDA, Emulate to Test Organs-on-Chips for Drug Toxins

A joint venture between Food and Drug Administration and a developer of chip devices simulating human organs, is evaluating the chips as a way to test new drugs for toxic effects. . . . → Read More: FDA, Emulate to Test Organs-on-Chips for Drug Toxins

Antibody Shows Promise Against Marburg Virus Infections

Tests with lab animals show an experimental synthetic antibody protects against deadly Marburg and Ravn viruses as long as 5 days following infections. . . . → Read More: Antibody Shows Promise Against Marburg Virus Infections

Prodrugs Designed to Better Target Cancer Therapies

A delivery mechanism is being developed to package cancer drugs in a nanoscale precursor state that reacts only in tumor regions, to protect against adverse effects. . . . → Read More: Prodrugs Designed to Better Target Cancer Therapies

CARB-X Commits $48M for Antibiotic Resistance R&D

A public-private partnership is spending $48 million in grants to biotechnology companies for research on treatments and diagnostics to counter antibiotic resistance, with half of that amount distributed immediately. . . . → Read More: CARB-X Commits $48M for Antibiotic Resistance R&D

Climate-Resistant Oilseed Crop Plant Developed

An academic-industry team developed a new crop plant variety that produces cooking oil like rapeseed or canola, but in a warmer and dryer climate. . . . → Read More: Climate-Resistant Oilseed Crop Plant Developed

Regeneron to Sequence 500K UK Biobank Genomes

A biotech company and health database center are partnering with drug maker GlaxoSmithKline to produce genomic data on 500,000 individuals for drug discovery. . . . → Read More: Regeneron to Sequence 500K UK Biobank Genomes

Inhaled Drug Shown Feasible for Postpartum Bleeding

Results from a clinical trial show a dry-powder inhaled form of the drug oxytocin works in the body much like the injected form, given to prevent postpartum hemorrhage, excessive bleeding in some women after childbirth. . . . → Read More: Inhaled Drug Shown Feasible for Postpartum Bleeding

Heart Assoc, Amazon Partner on Precision Medicine Data

American Heart Association and Amazon Web Services are collecting data from researchers to advance precision medicine in cardiovascular diseases and stroke. . . . → Read More: Heart Assoc, Amazon Partner on Precision Medicine Data

Allergan to Option Gene Editing for Eye Diseases

International drug maker Allergan is gaining access to treatments for inherited eye diseases being developed by Editas Medicine, a spin-off enterprise from MIT and Harvard. . . . → Read More: Allergan to Option Gene Editing for Eye Diseases